• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Surgery

Fluid replacement with hydroxyethyl starch linked with higher mortality

bys25qthea
February 19, 2013
in Surgery
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Feb 19th – In a study published today, hydroxyethyl starch use in fluid resuscitation associated with an increased risk of mortality.

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Hydroxyethyl starch use in fluid resuscitation associated with an overall mortality risk ratio of 1.07.

2. Excluding controversial Boldt et al studies, hydroxyethyl starch  is associated with an increased mortality risk ratio of 1.09.

Published today, this systematic review and meta-analysis indicates that hydroxyethyl starch, in comparison to 0.9% sodium chloride, Ringer’s lactate, Ringer’s acetate, gelatin, albumin, and plasma, significantly increased rates of mortality, acute renal failure, and renal replacement therapy. These results prove to be particularly important given the controversy concerning the use of hydroxyethyl starch over other volume expanders for critically ill patients. Advantages for the use of hydroxyethyl starch were originally shown in a series of studies by Joachim Boldt, many of which have since been retracted due to possible ethical and scientific misconduct. Excluding studies by Dr. Boldt, there was a 1.09 relative risk for mortality with the use of hydroxyethyl starch relative to other fluid types. Hence this study reinforces a growing notion that hydroxyethyl starch should not be used for acute fluid resuscitation in critically ill patients.

RELATED REPORTS

Intravenous fluid restriction does not improve septic shock outcomes

Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

Socioeconomically disadvantaged older persons are at greater risk of impairments after ICU hospitalization

A few limitations should be considered for this study. First, up to 95% of the trials included in the meta-analysis were determined to be of either unclear or high risk of bias. Secondly, most subgroup studies in the analysis were of a small sample size, predisposing the results to type II error. Nonetheless, this study provides a solid foundation for the decreased use of hydroxyethyl starch as a fluid resuscitation medium, and it serves as a foundation for further large scale studies into the appropriate selection of intravenous fluids for critically ill patients.

Click to read the study in JAMA

[/tab]

[tab]

Image: PD

1. Hydroxyethyl starch use in fluid resuscitation associated with an overall mortality risk ratio of 1.07.

2. Excluding controversial Boldt et al studies, hydroxyethyl starch  is associated with an increased mortality risk ratio of 1.09.

This [systematic review and meta-analysis]: The study was a meta-analysis of 38 randomized controlled trials involving 10,868 patients comparing hydroxyethyl starch to other fluid replacement therapies. Overall mortality risk ratio was calculated both with (RR, 1.07; 95%CI, 1.00 to 1.14) and without (RR, 1.09; 95% CI. 1.02 to 1.17) 7 Boldt et. al studies which have not been retracted. Mortality risk ratio of the 7 studies alone was 0.91 (95%CI, .74 to 1.12), showing no association between hydroxyethyl starch and mortality. Excluding the Boldt et. al trials, it was shown hydroxyethyl starch is associated with a significant risk of mortality.

Furthermore, hydroxyethyl starch significantly increased the risk of renal replacement therapy (RR, 1.32; 95%CI, 1.15 to 1.50) and acute renal failure (RR, 1.27; 95%CI, 1.09 to 1.47) when compared to other intravenous fluids.

In sum: This systematic review and meta-analysis indicates that hydroxyethyl starch, in comparison to 0.9% sodium chloride, Ringer’s lactate, Ringer’s acetate, gelatin, albumin, and plasma, significantly increased rates of mortality, acute renal failure, and renal replacement therapy. These results prove to be particularly important given the controversy concerning the use of hydroxyethyl starch over other volume expanders for critically ill patients. Advantages for the use of hydroxyethyl starch were originally shown in a series of studies by Joachim Boldt, many of which have since been retracted due to possible ethical and scientific misconduct. Excluding studies by Dr. Boldt, there was a 1.09 relative risk for mortality with the use of hydroxyethyl starch relative to other fluid types. Hence this study reinforces a growing notion that hydroxyethyl starch should not be used for acute fluid resuscitation in critically ill patients.

A few limitations should be considered for this study. First, upto 95% of the trials included in the meta-analysis were determined to be of either unclear or high risk of bias. Secondly, most subgroup studies in the analysis were of a small sample size, predisposing the results to type II error. Nonetheless, this study provides a solid foundation for the decreased use of hydroxyethyl starch as a fluid resuscitation medium, and it serves as a foundation for further large scale studies into the appropriate selection of intravenous fluids for critically ill patients.

Click to read the study in JAMA

By John Prendergass and Rif Rahman

More from this author: Protected sleep periods improve intern alertness and sleep duration, ADHD medication decreases rates of criminality in ADHD patients, Low dose aspirin shows net clinical benefit in patients with first unprovoked venous thromboembolism

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: fluid replacementhydroxyethyl starchICU
Previous Post

More U.S. women using emergency contraception pill

Next Post

Robotic-assisted hysterectomy lacks cost-benefit

RelatedReports

Hypotonic IVF linked to increased risk of hyponatremia
Emergency

Intravenous fluid restriction does not improve septic shock outcomes

June 27, 2022
Emergency

Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

June 27, 2022
Emergency

Socioeconomically disadvantaged older persons are at greater risk of impairments after ICU hospitalization

March 24, 2022
Chronic Disease

Three-step support strategy reduces prolonged grief in relatives after death of intensive care unit patients

February 23, 2022
Next Post

Robotic-assisted hysterectomy lacks cost-benefit

Researchers improve lung cancer risk model by incorporating more risk factors

Health care costs not reduced after bariatric surgery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.